Experience of observing patients with Duchenne myopathy
Duchenne muscular dystrophy is a genetically determined fatal disease with a steadily progressive course. It is characterized by the absence or sharp decrease (less than 3 % of the norm) of the dystrophin protein. In recent years, several drugs for pathogenetic treatment of Duchenne myodystrophy hav...
Saved in:
| Main Authors: | L. I. Minaycheva, E. Yu. Petlina, E. G. Ravzhaeva, G. N. Seitova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-12-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/444 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01) -
Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01) -
Understanding Duchenne muscular dystrophy-associated brain pathology
by: Minou A. T. Verhaeg, et al.
Published: (2025-07-01) -
Positive experience in treating patients with Duchenne muscular dystrophy caused by a nonsense mutation: family clinical case
by: L. S. Kraeva, et al.
Published: (2024-09-01) -
Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01)